ClinicalTrials HQ

REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men

REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men

Active, not recruiting · NCT04838769 · Registry updated 2026-09-14
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active MenGenital Diseases, Lower Urinary Tract Symptoms, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urological Manifestations, benign prostatic hyperplasia, male reproductive system disorder, prostate disorderActive, not recruitingNot applicable2026-09-14NCT04838769

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Boston Scientific Corporation148

21 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Australian Clinical TrialsWahroongaAustralia1
Centre Hospitalier du Pays d'AixAix-en-ProvenceFrance3
Centre Hospitalier Privé Saint GrégoireSaint-GrégoireFrance1
Centre Hospitalier Universitaire De LilleLilleFrance11
CHU d'AngersAngersFrance27
Chu de BordeauxBordeauxFrance66
CHU de NiceNiceFrance51
CHU de RennesRennesFrance32
CHU de RouenRouenFrance37
CHU de ToulouseToulouseFrance42
CHU GrenobleGrenobleFrance48
Clinique La Croix du SudQuint-FonsegrivesFrance5
Clinique PasteurToulouseFrance23
Clinique Saint HilaireRouenFrance4
Epworth HealthcareMelbourneAustralia2
Hospices Civils de LyonLyonFrance43
Hôpital BichatParisFrance9
Hôpital CochinParisFrance34
Hôpital privé FranchevillePérigueuxFrance1
Hôpital Privé La LouvièreLilleFrance2
Institut Mutualiste MontsourisParisFrance29